Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 67 and 292 of Human Napsin A|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.1M tris glycine, pH 7, with 10% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA5-28924 targets Napsin A in WB applications and shows reactivity with Human samples.
The PA5-28924 immunogen is recombinant fragment corresponding to a region within amino acids 67 and 292 of Human Napsin A.
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
asp 4; ASP4; aspartyl protease 4; KAP; Kdap; kidney-derived aspartic protease-like protein; NAPA; napsin-1; napsin-A; pronapsin A; SNAPA; TA01/TA02
KAP; Kdap; NAP1; NAPA; NAPSA; SNAPA